Search

everythinglearnresearchcommunity

for

Search:↓

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

No significant difference in iron deficiency between women with or without hair loss.

Iron deficiency may contribute to hair loss.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Low iron levels are linked to more hair loss in women with chronic hair shedding.

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

Eating a balanced diet with specific nutrients can help manage menopause symptoms and prevent related health issues.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Shaving and avoiding brushing improved the patient's beard hair condition.

The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document says that there are treatments for hair and nail diseases.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Minoxidil and finasteride effectively treat hair loss.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

No cure for female pattern hair loss, but various effective treatments exist.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.